| 國立成功大學 |
2022 |
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan
|
Chien, L.-H.;Chen, T.-Y.;Chen, Chen C.-H.;Chen, K.-Y.;Hsiao, C.-F.;Chang, G.-C.;Tsai, Y.-H.;Su, W.-C.;Huang, M.-S.;Chen, Y.-M.;Chen, Chen C.-Y.;Liang, S.-K.;Chen, Chen C.-Y.;Wang, C.-L.;Hung, Hung H.-H.;Jiang, H.-F.;Hu, J.-W.;Rothman, N.;Lan, Q.;Liu, T.-W.;Chen, Chen C.-J.;Yang, P.-C.;Chang, I.-S.;Hsiung, C.A. |
| 國立成功大學 |
2022 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study
|
Bai, L.-Y.;Li, C.-P.;Shan, Y.-S.;Chuang, S.-C.;Chen, J.-S.;Chiang, N.-J.;Chen, Y.-Y.;Tsou, H.-H.;Chuang, M.-H.;Chiu, Chiu C.-F.;Liu, T.-W.;Chen, L.-T. |
| 國立成功大學 |
2022 |
Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps
|
Liao, C.-T.;Wen, Y.-W.;Lee, S.-R.;Ng, S.-H.;Liu, T.-W.;Tsai, S.-T.;Tsai, M.-H.;Lin, J.-C.;Chien, Chien C.-Y.;Lou, P.-J.;Wang, C.-P.;Chu, P.-Y.;Leu, Y.-S.;Tsai, K.-Y.;Terng, S.-D.;Chen, T.-M.;Wang, C.-H.;Chen, W.-C.;Lee, Lee L.-Y.;Lin, C.-Y.;Wang, H.-M.;Fang, T.-J.;Huang, S.-F.;Kang, C.-J.;Chang, K.-P.;Yen, T.-C.;Yang, L.-Y.;Lin, C.-H.;Group, for the Taiwan Oral Cavity Cancer Advisory |
| 臺大學術典藏 |
2021-11-18T04:57:51Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-11-18T04:57:45Z |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin M.-C; Leu Y.-S; Chiang C.-J; JENG-YUH KO; Wang C.-P; Yang T.-L; Chen T.-C; Chen C.-N; Chen H.-L; Liao C.-T; Tsai S.-T; Lin J.-C; Chu P.-Y; Tsai K.-Y; Tsai M.-H; Huang H.-C; Yang M.-H; Wu Y.-H; Terng S.-D; Chien C.-Y; Liu T.-W; Lee W.-C; Lou P.-J. |
| 臺大學術典藏 |
2021-11-15T07:48:12Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-11-15T07:48:06Z |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin M.-C; Leu Y.-S; Chiang C.-J; JENG-YUH KO; Wang C.-P; Yang T.-L; Chen T.-C; Chen C.-N; Chen H.-L; Liao C.-T; Tsai S.-T; Lin J.-C; Chu P.-Y; Tsai K.-Y; Tsai M.-H; Huang H.-C; Yang M.-H; Wu Y.-H; Terng S.-D; Chien C.-Y; Liu T.-W; Lee W.-C; Lou P.-J. |
| 臺大學術典藏 |
2021-11-10T00:53:38Z |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin M.-C.; Leu Y.-S.; Chiang C.-J.; Ko J.-Y.; Wang C.-P.; Yang T.-L.; Chen T.-C.; Chen C.-N.; Chen H.-L.; Liao C.-T.; Tsai S.-T.; Lin J.-C.; Chu P.-Y.; Tsai K.-Y.; Tsai M.-H.; HUAI-CHENG HUANG; Yang M.-H.; Wu Y.-H.; Terng S.-D.; Chien C.-Y.; Liu T.-W.; Lee W.-C.; Lou P.-J. |
| 臺大學術典藏 |
2021-11-03T02:35:04Z |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin M.-C.; Leu Y.-S.; Chiang C.-J.; Ko J.-Y.; Wang C.-P.; Yang T.-L.; Chen T.-C.; Chen C.-N.; HSIN-LIN CHEN; Liao C.-T.; Tsai S.-T.; Lin J.-C.; Chu P.-Y.; Tsai K.-Y.; Tsai M.-H.; Huang H.-C.; Yang M.-H.; Wu Y.-H.; Terng S.-D.; Chien C.-Y.; Liu T.-W.; Lee W.-C.; Lou P.-J. |
| 臺大學術典藏 |
2021-09-04T05:17:07Z |
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan
|
Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Chen P.-J.; Liu C.-J.; Yu M.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:52Z |
Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report
|
Chen Y.C.; Wang C.H.; Lin D.T.; Lui P.T.; ANN-LII CHENG; Liu T.W.; Tsay W.; Tien H.F.; Liu M.C.; Chuu W.M. |
| 臺大學術典藏 |
2021-09-01T02:02:51Z |
Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades - Should peripheral T-cell lymphoma be considered separately?
|
ANN-LII CHENG; Chen Y.-C.; Wang C.-H.; Su I.-J.; Hsieh H.-C.; Chang J.-Y.; Hwang W.-S.; Su W.-C.; Liu T.-W.; Tien H.-F.; Tsai W.; Shen M.-C.; Liu C.-H. |
| 臺大學術典藏 |
2021-09-01T02:02:51Z |
Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classification
|
ANN-LII CHENG; Chen Y.-C.; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; Lai H.-S.; Liu T.-W.; Tien H.-F.; Shen M.-C.; Liu C.-H. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.; ANN-LII CHENG; Hsu C.; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:30Z |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Hsu C.; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; ANN-LII CHENG; Chen P.-J. |
| 臺大學術典藏 |
2021-09-01T01:53:40Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:27Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-31T06:29:20Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-31T06:29:16Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:35:20Z |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah H.-S.; Chao Y.; Chen L.-T.; Yao T.-J.; Huang J.-D.; Chang J.-Y.; PEI-JER CHEN; Chuang T.-R.; Chin Y.-H.; Whang-Peng J.; Liu T.-W. |
| 臺大學術典藏 |
2021-07-03T03:35:05Z |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Hsu C.; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Cheng A.-L.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:10Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:38Z |
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan
|
Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Liu C.-J.; Yu M.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:36Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group |
